PT99864A - Processo para a preparacao de novas composicoes farmaceuticas contendo antagonistas de receptor de quisqualato - Google Patents

Processo para a preparacao de novas composicoes farmaceuticas contendo antagonistas de receptor de quisqualato

Info

Publication number
PT99864A
PT99864A PT99864A PT9986491A PT99864A PT 99864 A PT99864 A PT 99864A PT 99864 A PT99864 A PT 99864A PT 9986491 A PT9986491 A PT 9986491A PT 99864 A PT99864 A PT 99864A
Authority
PT
Portugal
Prior art keywords
pharmaceutical compositions
compositions containing
receptor antagonists
new pharmaceutical
preparing new
Prior art date
Application number
PT99864A
Other languages
English (en)
Other versions
PT99864B (pt
Inventor
Helmut Dr Wachtel
Peter-Andreas Loeschmann
Lechoslaw Dr Turski
Thomas Klockgether
David Norman Dr Stephens
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19904041981 external-priority patent/DE4041981A1/de
Priority claimed from DE19914121483 external-priority patent/DE4121483A1/de
Application filed by Schering Ag filed Critical Schering Ag
Publication of PT99864A publication Critical patent/PT99864A/pt
Publication of PT99864B publication Critical patent/PT99864B/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PT99864A 1990-12-21 1991-12-19 Processo para a preparacao de novas composicoes farmaceuticas contendo antagonistas de receptor de quisqualato PT99864B (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19904041981 DE4041981A1 (de) 1990-12-21 1990-12-21 Neue verwendung von quisqualat-rezeptor-antagonisten
DE19914121483 DE4121483A1 (de) 1991-06-26 1991-06-26 Neue verwendung von quisqualat-rezeptor-antagonisten

Publications (2)

Publication Number Publication Date
PT99864A true PT99864A (pt) 1992-12-31
PT99864B PT99864B (pt) 1999-06-30

Family

ID=25899840

Family Applications (1)

Application Number Title Priority Date Filing Date
PT99864A PT99864B (pt) 1990-12-21 1991-12-19 Processo para a preparacao de novas composicoes farmaceuticas contendo antagonistas de receptor de quisqualato

Country Status (12)

Country Link
US (1) US6191132B1 (pt)
EP (1) EP0516795B1 (pt)
JP (1) JPH05505830A (pt)
AT (1) ATE180405T1 (pt)
AU (1) AU655958B2 (pt)
CA (1) CA2076524A1 (pt)
DE (1) DE59109130D1 (pt)
HU (1) HUT61467A (pt)
IE (1) IE914526A1 (pt)
IL (1) IL100458A (pt)
PT (1) PT99864B (pt)
WO (1) WO1992011012A1 (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT647137E (pt) * 1992-06-22 2008-11-24 Univ California Antagonistas dos receptores da glicina e a sua utilização
US5631373A (en) 1993-11-05 1997-05-20 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon, Eugene Oregon Alkyl, azido, alkoxy, and fluoro-substituted and fused quinoxalinediones
US5922715A (en) * 1997-02-18 1999-07-13 American Home Products Corporation 5-aminoalkoxy-1, 4-dihydroquinoxaline-2, 3-diones
WO1998035948A1 (en) * 1997-02-18 1998-08-20 American Home Products Corporation 5-aminoalkoxy-1,4-dihydroquinoxaline-2,3-diones being dopamine agonists
DE10053397A1 (de) * 2000-10-20 2002-05-02 Schering Ag Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen
DE10043321B4 (de) * 2000-08-24 2005-07-28 Neurobiotec Gmbh Verwendung eines transdermalen therapeutischen Systems zur Behandlung der Parkinsonschen Krankheit, zur Behandlung und Prävention des prämenstruellen Syndroms und zur Lactationshemmung
DE10064453A1 (de) * 2000-12-16 2002-07-04 Schering Ag Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen
WO2004110255A2 (en) 2003-06-09 2004-12-23 Gang Zheng Antineoplastic agents targeted via glut transporters
AU2006234627C1 (en) * 2005-04-08 2009-11-26 Eisai R & D Management Co., Ltd. Therapeutic agent for dyskinesia
WO2009054544A1 (en) * 2007-10-26 2009-04-30 Eisai R & D Management Co., Ltd. Ampa receptor antagonists for parkinson's disease and movement disorders
EP2338492A1 (en) * 2009-12-24 2011-06-29 Universidad del Pais Vasco Methods and compositions for the treatment of alzheimer

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5852219A (ja) * 1981-09-22 1983-03-28 Sumitomo Chem Co Ltd パ−キンソン病治療剤
US4812458A (en) * 1986-09-16 1989-03-14 A/S Ferrosan 6,7-disubstituted-2,3-dihydroxyquinoxaline compounds, pharmaceutical compositions thereof, and their use as neuroleptics
IE66149B1 (en) * 1986-09-16 1995-12-13 Novo Nordisk As Quinoxaline compounds and their preparation and use
DK146787A (da) 1987-03-23 1988-09-24 Ferrosan Heterocykliske forbindelser, deres fremstilling og anvendelse
NO179551C (no) 1987-11-10 1996-10-30 Novo Nordisk As Analogifremgangsmåte for fremstilling av terapeutisk virksomme kinoxalinforbindelser
DK160941C (da) 1988-06-28 1991-10-21 Novo Nordisk As Kondenserede 2,3-dihydroxypyraziner, fremgangsmaade til deres fremstilling og farmaceutiske praeparater, hvori forbindelserne indgaar
DK338789A (da) * 1988-07-15 1990-01-16 Schering Ag 2-substituerede ergolinylurinstofderivater og fremgangsmaade til fremstilling deraf, deres anvendelse som laegemidler samt mellemprodukter til fremstilling deraf
DK715888D0 (da) 1988-12-22 1988-12-22 Ferrosan As Quinoxalinforbindelser, deres fremstilling og anvendelse
US4975430A (en) * 1989-06-16 1990-12-04 The State Of Oregon Acting By And Through The State Board Of Education On Behalf Of The Oregon Health Sciences University CNQX and its analogs as therapeutics for degenerative neural diseases

Also Published As

Publication number Publication date
EP0516795B1 (de) 1999-05-26
CA2076524A1 (en) 1992-06-21
DE59109130D1 (de) 1999-07-01
JPH05505830A (ja) 1993-08-26
WO1992011012A1 (de) 1992-07-09
US6191132B1 (en) 2001-02-20
ATE180405T1 (de) 1999-06-15
AU655958B2 (en) 1995-01-19
IL100458A0 (en) 1992-09-06
IL100458A (en) 1996-12-05
EP0516795A1 (de) 1992-12-09
HU9202990D0 (en) 1992-12-28
HUT61467A (en) 1993-01-28
PT99864B (pt) 1999-06-30
AU9139791A (en) 1992-07-22
IE914526A1 (en) 1992-07-01

Similar Documents

Publication Publication Date Title
MX9801305A (es) Composicion de disolucion rapida oral para agonistas de dopamina.
ATE175114T1 (de) Pharmazeutische zusammensetzungen enthaltend einen opiat antagonist und calcium salze, ihre verwendung zur behandlung von endorphin- vermittelten krankheiten
NL970006I2 (nl) Gebruik van indolon-derivaten voor het bereiden van geneesmiddelen ter behandeling van de ziekte vanParkinson.
SE8704248D0 (sv) Medical use
DE3581699D1 (de) Bis-dimethoxymethyl(trimethoxybenzyl)isochinolinium-salze, ihre herstellung und diese enthaltende pharmazeutische zusammensetzungen.
UA34416C2 (uk) Похідні хроману, активні стосовно 5-нт рецептора, спосіб їх одержання та проміжні сполуки
PT99864A (pt) Processo para a preparacao de novas composicoes farmaceuticas contendo antagonistas de receptor de quisqualato
BR0013311A (pt) Derivados substituìdos de 1,5-dihidropirrol-2-ona eficazes como antagonistas de receptores nmda para o tratamento de estados de dor
ES2052028T3 (es) Un metodo para preparar compuestos diarilicos anti-ateroscleroticos.
ES2111352T3 (es) Uso de diester fosfato para el tratamiento de enfermedades retinianas.
FR2717812B1 (fr) Indeno[1,2-e]pyrazine-4-ones, leur préparation et les médicaments les contenant.
MY103790A (en) Novel compound for the treatment of several bone affecting diseases
LV10607A (lv) Jauni bicikliski aminoaizvietoti savienojumi
BR9610175A (pt) Composto processo de preparação do composto composição farmacêutica e utilização do composto
HU9503099D0 (en) New piperazinyl-alkylthio-pyrimidine derivatives, pharmaceutical compositions containing them, and process for producing the active components
BR9306870A (pt) Derivados farmacologicamente ativos de (aminometila terciária) - benzenometanol
ES483288A1 (es) Un procedimiento para la preparacion de nuevas dibenzo (a,d)ciclohepten-5,10-iminas sustituidas
GB2004550A (en) Dibenzocycloocten-imines
CA2033975A1 (en) Use of .beta.-receptor blocking agents
BR9812862A (pt) Composto, formulação farmacêutica, e, processo para a preparação de um composto
MX9601659A (es) Antagonistas del receptor de adhesion, procedimiento para prepararlos, composiciones farmaceuticas que los contienen y su empleo para preparar medicamentos y combatir enfermedades.
IT1246790B (it) Composizioni farmaceutiche per il trattamento del morbo di parkinson

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19921021

FG3A Patent granted, date of granting

Effective date: 19990301

MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20000930